Nuove_emissioni, collocamenti Nuove Emissioni (2 lettori)

[gionmorg]

New bond issue: Teva Pharmaceutical Industries sells USD 1000m in 2014 bonds with 1.70% coupon

Teva Pharmaceutical Industries (Israel) on November 7, 2011 placed USD 1000m in bonds with a 1.70% coupon, maturing in 2014.The deal was done via SPV Teva Pharmaceutical Finance IV, LLC. The bond was priced at 99.869% to yield 1.745%. Barclays Capital, BNP Paribas, Citigroup, Credit Suisse, Goldman Sachs, HSBC, JP Morgan, Morgan Stanley arranged the deal.

inShare


Issuer, issue number: Teva Pharmaceutical Industries, 2014-3
Type of debt instrument: Eurobonds
Issue status: outstanding
Type of placement: public
Par, currency of issue: USD, 2000
Amount: 1 000 000 000
ISIN: US88166HAA59
End of placement: Nov 07 2011
Issue price: 99.869
Yield at Pricing: 1.745%
Coupon: 1.70%
Coupon frequency: 2 time(s) per year
Settlement Date: Nov 10 2011
Maturity date: Nov 10 2014
Issue Managers: Barclays Capital, BNP Paribas, Citigroup, Credit Suisse, Goldman Sachs, HSBC, JP Morgan, Morgan Stanley
Issuer profile:
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients. Teva is among the top 15 pharmaceutical companies and among the largest generic pharmaceutical companies in the world.

Outstanding issues:
11 issue(s) outstanding worth USD 8 250 000 000

 

[gionmorg]

New bond issue: Teva Pharmaceutical Industries sells USD 950m in 2016 bonds with 2.40% coupon

Teva Pharmaceutical Industries (Israel) on November 7, 2011 placed USD 950m in bonds with a 2.40% coupon, maturing in 2016.The deal was done via SPV Teva Pharmaceutical Finance Company B.V.. The bond was priced at 99.916% to yield 2.418%. Barclays Capital, BNP Paribas, Citigroup, Credit Suisse, Goldman Sachs, HSBC, JP Morgan, Morgan Stanley arranged the deal.

inShare


Issuer, issue number: Teva Pharmaceutical Industries, 2016
Type of debt instrument: Eurobonds
Issue status: outstanding
Type of placement: public
Par, currency of issue: USD, 2000
Amount: 950 000 000
ISIN: US88165FAC68
End of placement: Nov 07 2011
Issue price: 99.916
Yield at Pricing: 2.418%
Coupon: 2.40%
Coupon frequency: 2 time(s) per year
Settlement Date: Nov 10 2011
Maturity date: Nov 10 2016
Issue Managers: Barclays Capital, BNP Paribas, Citigroup, Credit Suisse, Goldman Sachs, HSBC, JP Morgan, Morgan Stanley
Issuer profile:
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients. Teva is among the top 15 pharmaceutical companies and among the largest generic pharmaceutical companies in the world.

Outstanding issues:
11 issue(s) outstanding worth USD 8 250 000 000

 

[gionmorg]

New bond issue: Teva Pharmaceutical Industries sells USD 875m in 2021 bonds with 3.650% coupon

Teva Pharmaceutical Industries (Israel) on November 7, 2011 placed USD 875m in bonds with a 3.650% coupon, maturing in 2021.The deal was done via SPV Teva Pharmaceutical Finance Company B.V.. The bond was priced at 99.635% to yield 3.694%. Barclays Capital, BNP Paribas, Citigroup, Credit Suisse, Goldman Sachs, HSBC, JP Morgan, Morgan Stanley arranged the deal.

inShare


Issuer, issue number: Teva Pharmaceutical Industries, 2021-1
Type of debt instrument: Eurobonds
Issue status: outstanding
Type of placement: public
Par, currency of issue: USD, 2000
Amount: 875 000 000
ISIN: US88165FAF99
End of placement: Nov 07 2011
Issue price: 99.635
Yield at Pricing: 3.694%
Coupon: 3.650%
Coupon frequency: 2 time(s) per year
Settlement Date: Nov 10 2011
Maturity date: Nov 10 2021
Issue Managers: Barclays Capital, BNP Paribas, Citigroup, Credit Suisse, Goldman Sachs, HSBC, JP Morgan, Morgan Stanley
Issuer profile:
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients. Teva is among the top 15 pharmaceutical companies and among the largest generic pharmaceutical companies in the world.

Outstanding issues:
11 issue(s) outstanding worth USD 8 250 000 000

 

[gionmorg]

New bond issue: Teva Pharmaceutical Industries sells USD 875m in 2021 bonds with 3.650% coupon

Teva Pharmaceutical Industries (Israel) on November 7, 2011 placed USD 875m in bonds with a 3.650% coupon, maturing in 2021.The deal was done via SPV Teva Pharmaceutical Finance IV B.V.. The bond was priced at 99.635% to yield 3.694%. Barclays Capital, BNP Paribas, Citigroup, Credit Suisse, Goldman Sachs, HSBC, JP Morgan, Morgan Stanley arranged the deal.

inShare


Issuer, issue number: Teva Pharmaceutical Industries, 2021-2
Type of debt instrument: Eurobonds
Issue status: outstanding
Type of placement: public
Par, currency of issue: USD, 2000
Amount: 875 000 000
End of placement: Nov 07 2011
Issue price: 99.635
Yield at Pricing: 3.694%
Coupon: 3.650%
Coupon frequency: 2 time(s) per year
Settlement Date: Nov 10 2011
Maturity date: Nov 10 2021
Issue Managers: Barclays Capital, BNP Paribas, Citigroup, Credit Suisse, Goldman Sachs, HSBC, JP Morgan, Morgan Stanley
Issuer profile:
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals as well as active pharmaceutical ingredients. Teva is among the top 15 pharmaceutical companies and among the largest generic pharmaceutical companies in the world.

Outstanding issues:
11 issue(s) outstanding worth USD 8 250 000 000

 

[gionmorg]

New bond issue: Korea Finance Corporation sells USD 750m in 2021 bonds with 4.625% coupon

Korea Finance Corporation on November 8, 2011 placed USD 750m in bonds with a 4.625% coupon, maturing in 2021. The bond was priced at 99.6990%. Bank of America Merrill Lynch, Credit Suisse, RBS, Daewoo Securities arranged the deal.

inShare


Issuer, issue number: Korea Finance Corporation, 2021
Type of debt instrument: Eurobonds
Issue status: outstanding
Type of placement: public
Par, currency of issue: USD, 200000
Amount: 750 000 000
End of placement: Nov 08 2011
Issue price: 99.699
Coupon: 4.625%
Coupon frequency: 2 time(s) per year
Settlement Date: Nov 16 2011
Maturity date: Nov 16 2021
Issue Managers: Bank of America Merrill Lynch, Credit Suisse, RBS, Daewoo Securities
Issuer profile:
Korea Finance Corporation operates as a financing company in South Korea. It provides finance to small and medium enterprises, Key growth engines or businesses, and SOC and regional development projects, as well as to high-tech, new materials, and new or renewable energy industries. The company also supports the structural enhancement of the financial industry. Korea Finance Corporation was founded in 2009 and is based in Seoul, South Korea

Outstanding issues:
4 issue(s) outstanding worth USD 1 600 000 000
1 issue(s) outstanding worth CHF 175 000 000
3 issue(s) outstanding worth JPY 30 000 000 000

 

[gionmorg]

Che ci dovrà fa teva con 5 mld di USD!!!! Aria di shopping nel settore pharma?

 

[gionmorg]

Telstra issued EUR benchmark bond with a maturity of 11 years
Guidance: mid swaps +155 basis points
Telstra issued a EUR benchmark bond with a maturity of 11 years. The transaction is supported by BNP Paribas, HSBC Bank and German. Expect a spread of 155 basis points over mid swaps. of the transaction:

Issuer: Telstra Corporation Limited
Ratings: A2, A (neg), A (neg)
Volume: n.bek. (EUR benchmark)
Running Time: 11 years
Guidance: Mid swap +155 bp
Denomination: EUR 1,000
Listing: London, Angew.
Law: English Law
Bookrunner: BNP Paribas, German Bank, HSBC

 

[gionmorg]

New bond issue: IDBI Bank sells CNY 650m in 2014 bonds with 4.50% coupon

IDBI Bank (India) on November 14, 2011 placed CNY 650m in bonds with a 4.50% coupon, maturing in 2014.The deal was done via IDBI Bank Ltd, DIFC Branch. The bond was priced at 100%. HSBC arranged the deal.

inShare


Issuer, issue number: IDBI Bank, 2014, CNY
Type of debt instrument: Eurobonds
Issue status: outstanding
Type of placement: public
Par, currency of issue: CNY, 1000000
Amount: 650 000 000
ISIN: XS0707560560
End of placement: Nov 14 2011
Issue price: 100
Yield at Pricing: 4.5%
Coupon: 4.50%
Coupon frequency: 2 time(s) per year
Settlement Date: Nov 18 2011
Maturity date: Nov 18 2014
Issue Managers: HSBC
Issuer profile:
IDBI Bank Ltd. is a Universal Bank with its operations driven by a cutting edge core Banking IT platform. The Bank offers personalized banking and financial solutions to its clients in the retail and corporate banking arena through its large network of Branches and ATMs, spread across length and breadth of India. We have also set up an overseas branch at Dubai and have plans to open representative offices in various other parts of the Globe, for encashing emerging global opportunities. As on March 31, 2010, the Bank had a network of 720 Branches and 1210 ATMs and plans to roll out another 300 branches during FY 2010-11. The Bank's total business, during Fy 2009-10, reached Rs. 3.06 Lakh Crore (up by 41.7 %), Balance sheet reached Rs. 2.34 Lakh Crore (up by 35.5 %) while it earned a net profit of Rs. 1031 Crore (up by 20 %). Our vision for the Bank is for it to be the trusted partner in progress, by leveraging quality human capital and setting global standards of excellence, to build the most valued financial conglomerate. Our experience of financial markets helps us to effectively cope with challenges and capitalize on the emerging opportunities by participating effectively in our country’s growth process.

Outstanding issues:
1 issue(s) outstanding worth USD 350 000 000
1 issue(s) outstanding worth CNY 650 000 000

 

[gionmorg]

APASSIONATA goes 5-year corporate bond with a coupon of 8.25%
Subscription period: 14.11.-12.30.2011
APASSIONATA issuing a corporate bond (ISIN: A1MA2Q) with a volume of up to 6 million €. Issuer is the Peter Massine Entertainment Inc. The subscription period runs on the Hamburg Stock Exchange on 14 November to 30 December 2011. Then the listing in the OTC is scheduled at the same venue. The bearer bond has a coupon of 8.25%, five-year term, and is designed with 1.000 € minimum subscription amount for private investors. APASSIONATA financed with the proceeds of the bond-starting the 2012 Tour in the U.S. and Canada. According to Peter Massine, namesake and CEO of the Peter Massine Entertainment GmbH. "We bring the horse lovers in North America to enjoy a specially developed for this market show" The tour starts on 27 April 2012 and over a period of 18 months with 66 shows in major cities of North America's guest appearance. APASSIONATA - solid growth in nearly a decade is one of the most successful APASSIONATA promoter of live entertainment shows in Europe. The privately held company has developed since its inception in 2002 the major European markets and achieved solely during the recent tour of over 21 million € turnover. APASSIONATA avoids unlike some other market participants as many fixed costs as possible. Horses, riders and artists will be engaged for the duration of the show tours. This allows a flexible response to unforeseen developments. Sun APASSIONATA currently serves as the current is no longer less profitable Spanish market. Thanks to this prudence APASSIONATA is still largely equity financed. "On credit, we have dispensed with our prudent growth strategy deliberately," explains Peter Massine proud. "The substantial initial investment for the North American tour offers investors the unique opportunity to participate in the economic success of APASSIONATA."






Key data of the bond:
Volume: up to € 6 million
Coupon: 8.25% pa
Term: 5 years to 31 October 2016
Denomination / Minimum Investment: 1000 €
Subscription period: 14 November to 30 December 2011
Listing: Open Market in Hamburg
WKN / ISIN: A1MA2Q/DE000A1MA2Q0
Issuer: Peter Massine Entertainment

 

[bulogna]

APASSIONATA goes 5-year corporate bond with a coupon of 8.25%
Subscription period: 14.11.-12.30.2011
APASSIONATA issuing a corporate bond (ISIN: A1MA2Q) with a volume of up to 6 million €. Issuer is the Peter Massine Entertainment Inc. The subscription period runs on the Hamburg Stock Exchange on 14 November to 30 December 2011. Then the listing in the OTC is scheduled at the same venue. The bearer bond has a coupon of 8.25%, five-year term, and is designed with 1.000 € minimum subscription amount for private investors. APASSIONATA financed with the proceeds of the bond-starting the 2012 Tour in the U.S. and Canada. According to Peter Massine, namesake and CEO of the Peter Massine Entertainment GmbH. "We bring the horse lovers in North America to enjoy a specially developed for this market show" The tour starts on 27 April 2012 and over a period of 18 months with 66 shows in major cities of North America's guest appearance. APASSIONATA - solid growth in nearly a decade is one of the most successful APASSIONATA promoter of live entertainment shows in Europe. The privately held company has developed since its inception in 2002 the major European markets and achieved solely during the recent tour of over 21 million € turnover. APASSIONATA avoids unlike some other market participants as many fixed costs as possible. Horses, riders and artists will be engaged for the duration of the show tours. This allows a flexible response to unforeseen developments. Sun APASSIONATA currently serves as the current is no longer less profitable Spanish market. Thanks to this prudence APASSIONATA is still largely equity financed. "On credit, we have dispensed with our prudent growth strategy deliberately," explains Peter Massine proud. "The substantial initial investment for the North American tour offers investors the unique opportunity to participate in the economic success of APASSIONATA."






Key data of the bond:
Volume: up to € 6 million
Coupon: 8.25% pa
Term: 5 years to 31 October 2016
Denomination / Minimum Investment: 1000 €
Subscription period: 14 November to 30 December 2011
Listing: Open Market in Hamburg
WKN / ISIN: A1MA2Q/DE000A1MA2Q0
Issuer: Peter Massine Entertainment

Volume 6 milioni .........
Se lo dicevano prima noi del forum gli compravamo tutto